Menu
GeneBe

rs199476318

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PP2PP3_Moderate

The NM_001018005.2(TPM1):c.715G>A(p.Ala239Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A239A) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)

Consequence

TPM1
NM_001018005.2 missense

Scores

14
4
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4O:1

Conservation

PhyloP100: 10.0
Variant links:
Genes affected
TPM1 (HGNC:12010): (tropomyosin 1) This gene is a member of the tropomyosin family of highly conserved, widely distributed actin-binding proteins involved in the contractile system of striated and smooth muscles and the cytoskeleton of non-muscle cells. Tropomyosin is composed of two alpha-helical chains arranged as a coiled-coil. It is polymerized end to end along the two grooves of actin filaments and provides stability to the filaments. The encoded protein is one type of alpha helical chain that forms the predominant tropomyosin of striated muscle, where it also functions in association with the troponin complex to regulate the calcium-dependent interaction of actin and myosin during muscle contraction. In smooth muscle and non-muscle cells, alternatively spliced transcript variants encoding a range of isoforms have been described. Mutations in this gene are associated with type 3 familial hypertrophic cardiomyopathy and dilated cardiomyopathy 1Y. [provided by RefSeq, Jun 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 9 uncertain in NM_001018005.2
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, TPM1
PP3
MetaRNN computational evidence supports a deleterious effect, 0.906

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TPM1NM_001018005.2 linkuse as main transcriptc.715G>A p.Ala239Thr missense_variant 8/10 ENST00000403994.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TPM1ENST00000403994.9 linkuse as main transcriptc.715G>A p.Ala239Thr missense_variant 8/101 NM_001018005.2 A1P09493-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:3Other:1
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicNov 10, 2020- -
Uncertain significance, no assertion criteria providedprovider interpretationStanford Center for Inherited Cardiovascular Disease, Stanford UniversityMay 24, 2017GENETIC TEST RESULTS This patient was diagnosed with DCM at age 5 months and underwent heart transplant at age 3 years. She had an Arrhythmia and Cardiomyopathy Comprehensive Panel with the Invitae laboratory. The following 120 genes were evaluated for sequence changes and exonic deletions/duplications: ABCC9, ACADVL, ACTC1, ACTN2, AGL, AKAP9, ALMS1, ANK2, ANKRD1, BAG3, CACNA1C, CACNA2D1, CACNB2, CALM1, CALM2, CALM3, CALR3, CASQ2, CAV3, CHRM2, CPT2, CRYAB, CSRP3, CTF1, CTNNA3, DES, DMD, DNAJC19, DOLK, DSC2, DSG2, DSP, DTNA, ELAC2, EMD, EYA4, FHL1, FHL2, FKRP, FKTN, FLNC, GAA, GATA4, GATA6, GATAD1, GJA5, GLA, GPD1L, HCN4, ILK, JPH2, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNE5, KCNH2, KCNJ2, KCNJ5, KCNJ8, KCNK3, KCNQ1, LAMA4, LAMP2, LDB3, LMNA, LRRC10, MTO1, MYBPC3, MYH6, MYH7, MYL2, MYL3, MYL4, MYLK2, MYOM1, MYOZ2, MYPN, NEBL, NEXN, NKX2-5, NPPA, PDLIM3, PKP2, PLEKHM2, PLN, PRDM16, PRKAG2, RAF1, RANGRF, RBM20, RYR2, SCN10A, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SGCD, SLC22A5, SLMAP, SNTA1, TAZ, TCAP, TGFB3, TMEM43, TMEM70, TMPO, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TRPM4, TTN, TTR, TXNRD2, VCL The following gene was evaluated for sequence changes only: SDHA. Results show that two variants were detected: · p.Ala239Thr (A239T; c.715G>A) in the TPM1 gene · p.Ser52Cys (S52C; c.155C>G) in the ELAC2 gene We suspect that the TPM1 variant may play a role in this patient’s heart condition, although there is not yet enough evidence to say that with certainty. p.Ala239Thr (A239T; c.715G>A) in exon 8 of the TPM1 gene (NM_001018005.1) Chromosome position: 15:63354787 G / A Based on the information reviewed below, we classify Ala239Thr as a VUS, probably disease-causing, concluding that there is not sufficient evidence at this time for its pathogenicity to warrant using it for predictive genetic testing. However, we do feel it is a good candidate to be pathogenic, and we plan to do additional testing to see if it is de novo in our patient. This variant has previously been reported in at least 2 unrelated individuals with cardiomyopathy. There is no published segregation data. It was reported by Hershberger et al. (2010) in an individual with familial dilated cardiomyopathy (PMID: 20215591). It was reported by Walsh et al. (2016) in an individual with hypertrophic cardiomyopathy who was sequenced at the Oxford Medical Genetics Laboratory (PMID: 27532257). It has not been submitted to ClinVar by a clinical testing laboratory as of December 12, 2016. This is a nonconservative amino acid change, resulting in the replacement of a nonpolar Alanine with a polar Threonine. Alanine at this location is absolutely conserved across ~100 vertebrate species for which we have data, as are multiple surrounding residues. According to the Invitae report, in silico algorithms do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). A nearby missense variant (+/- 10 amino acids) has been submitted to ClinVar by multiple laboratories as solidly Pathogenic for dilated cardiomyopathy: p.Asp230Asn. The molecule is in a coiled coil structure that is formed by 2 polypeptide chains in close association with actin. The sequence exhibits a prominent seven-residues periodicity. In total the variant has not been seen in >140,000 published controls and individuals from publicly available population datasets. The variant was not observed in 246 published controls from multiple ethnicities (Hershberger et al. 2010). There is no variation at this residue listed in the NHLBI Exome Sequencing Project dataset (http://evs.gs.washington.edu/EVS/), which currently includes variant calls on ~4300 Caucasian and ~2200 African American individuals. The phenotype of the ESP individuals is not publicly available, however the cohorts that were merged to create this dataset were all either general population samples or samples recruited for common cardiovascular disease such as hyper -
not provided, no classification providedcurationLeiden Muscular Dystrophy (TPM1)Apr 15, 2012- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxApr 07, 2022Reported in the published literature in one individual with familial DCM and one individual with HCM (Hershberger et al., 2010; Walsh et al., 2017); Reported in ClinVar in a patient who was diagnosed with DCM at age 5 months and underwent heart transplant at age 3 years (ClinVar Variant ID#31895; SCV000924969.1); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27532257, 20215591) -
Hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingInvitaeMar 16, 2018This sequence change replaces alanine with threonine at codon 239 of the TPM1 protein (p.Ala239Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. This variant is not present in population databases (rs199476318, ExAC no frequency). This variant has been reported in individuals affected with dilated cardiomyopathy (PMID: 20215591, Invitae) and hypertrophic cardiomyopathy (PMID: 27532257). ClinVar contains an entry for this variant (Variation ID: 31895). In summary, this variant is a rare missense change with uncertain impact on protein function. While it is absent from the population and reported in affected individuals, the available evidence is currently insufficient to determine its role in disease. Therefore, it has been classified as a Variant of Uncertain Significance Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). Missense variants that are absent from the ExAC population database have been shown to be significantly overrepresented in individuals with hypertrophic and dilated cardiomyopathy (PMID: 27532257). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.76
CardioboostCm
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.59
D
BayesDel_noAF
Pathogenic
0.61
Cadd
Pathogenic
32
Dann
Pathogenic
1.0
Eigen
Pathogenic
1.1
Eigen_PC
Pathogenic
1.1
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.86
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.59
D
MetaRNN
Pathogenic
0.91
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.7
H;H;H;.;H;H;H;H;.;.;.;.;.;.;.
MutationTaster
Benign
1.0
D;D;D;D;D;D;D;D;D;D;D;D;D
PrimateAI
Pathogenic
0.89
D
PROVEAN
Uncertain
-3.1
D;D;D;D;D;D;D;.;.;D;D;.;D;D;D
REVEL
Pathogenic
0.85
Sift
Uncertain
0.013
D;D;D;D;D;D;D;.;.;D;D;.;D;D;D
Sift4G
Uncertain
0.021
D;D;D;D;D;D;D;.;.;D;D;.;D;D;D
Polyphen
1.0, 0.91
.;.;D;D;.;.;.;D;.;.;.;.;.;P;.
Vest4
0.87
MVP
0.96
MPC
2.4
ClinPred
1.0
D
GERP RS
6.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.58
gMVP
0.93

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199476318; hg19: chr15-63354787; API